Lunai Bioworks Inc.【LNAI】
| Mar 31, 2012 | Mar 31, 2013 | Dec 31, 2014 | Jun 30, 2016 | Jun 30, 2017 | Jun 30, 2018 | Jun 30, 2019 | Jun 30, 2021 | Jun 30, 2022 | Jun 30, 2023 | Jun 30, 2024 |
|---|
| NET LOSS | -29,945 | -37,589 | -2,370,883 | -1,735,239 | -2,392,830 | 471 | -18,016,480 | -26,723,607 | -113,433,392 | -39,684,056 | -80,650,172 |
|---|
| Depreciation and amortization | - | - | 45,201 | 27,395 | 14,528 | 3 | 71,709 | 123,535 | 123,590 | 113,496 | 121,859 |
|---|
| Change in fair value of contingent consideration | - | - | - | - | - | - | - | -3,048,033 | 3 | - | 5 |
|---|
| Loss on extinguishment of debt | - | - | - | - | - | - | - | - | - | - | -1,303,578 |
|---|
| Non-cash stock-based compensation expense | - | - | - | - | - | - | - | - | - | - | 5 |
|---|
| Non-cash restricted shares issued for services rendered | - | - | - | - | - | - | - | - | - | 228,000 | 5 |
|---|
| Intangible asset impairment | - | - | - | - | - | - | - | - | - | - | 43 |
|---|
| Goodwill impairment | - | - | - | - | - | - | - | - | - | - | 12 |
|---|
| Amortization of discount on note payable | - | - | - | - | - | - | - | -296,505 | -297,212 | -348,621 | 580,605 |
|---|
| Insurance receivable | - | - | - | - | -471,641 | -108,005 | -119,831 | -342 | -1,594 | -46 | 1 |
|---|
| Prepaid expenses/deposits | - | - | - | - | 19,828 | 138,841 | 160,940 | -733,739 | -461,310 | -1,070,249 | -1,082,267 |
|---|
| Accounts payable | - | - | 162,950 | 574,975 | -652,785 | 119,575 | -29,946 | -272,318 | 1 | 4 | 4 |
|---|
| Other current liabilities | - | - | - | - | - | - | - | 30,004 | 24,056 | -54,060 | - |
|---|
| Operating leases, net | - | - | - | - | - | - | - | - | - | -27,224 | 11,284 |
|---|
| Accrued expenses | - | - | - | - | - | - | - | - | - | -578,809 | 5 |
|---|
| NET CASH USED IN OPERATING ACTIVITIES | -24,945 | -30,092 | -2,034,175 | -1,472,289 | - | -4,338,269 | -8,507,341 | -20,610,723 | -15,732,336 | -11,774,549 | -10,971,430 |
|---|
| Notes receivable prior to acquisition | - | - | - | - | - | - | - | - | - | - | 1 |
|---|
| Cash received from acquisition, net | - | - | - | - | - | - | - | - | - | - | 65,851 |
|---|
| Purchase of property and equipment | - | - | - | - | - | 30,000 | 716,669 | 48,892 | 5,156 | 29,774 | 70,430 |
|---|
| NET CASH USED IN INVESTING ACTIVITIES | -13,219 | -13,219 | -1,952,034 | 1 | - | -575,732 | -716,669 | -48,892 | -5,156 | -29,774 | -1,260,179 |
|---|
| Repayments of finance agreement | - | - | - | - | - | - | - | - | - | - | 870,073 |
|---|
| Proceeds from exercise of warrants | - | - | - | - | - | - | 6 | 82,056 | 130,000 | 2 | 341,865 |
|---|
| Proceeds from private placements | - | - | - | - | - | - | - | 5 | - | 4 | 3 |
|---|
| Proceeds from issuance of promissory notes | - | - | - | - | - | - | - | - | - | - | 4 |
|---|
| Proceeds from convertible notes payable | - | - | - | - | 413,670 | - | - | - | - | - | 4 |
|---|
| NET CASH PROVIDED BY FINANCING ACTIVITIES | 38,500 | 75,000 | 7 | - | - | 17 | 6 | 33 | 4 | 5 | 11 |
|---|
| Effect of exchange rates on cash | - | - | - | - | - | - | - | - | -5,240 | -8,395 | 60,141 |
|---|
| NET INCREASE (DECREASE) IN CASH | - | - | - | - | - | - | - | 12 | -11,492,268 | -7,297,662 | -1,654,013 |
|---|
| Interest | - | - | - | - | - | - | 43 | 89,224 | 79,716 | 352,334 | 20,128 |
|---|
| Income Taxes | - | - | - | - | 64,003 | - | - | 37 | 34 | - | - |
|---|
| Finance agreement entered into in exchange for prepaid assets | - | - | - | - | - | - | - | 607,250 | 666,875 | 1 | 906,834 |
|---|
| Conversion of note payable for issuance of preferred stock | - | - | - | - | - | - | - | - | - | - | 2 |
|---|
| Note payable settled through non-cash exercise of warrants | - | - | - | - | - | - | - | - | - | - | 2 |
|---|
| Debt discount related to notes payable | - | - | - | - | - | - | - | - | - | - | 339,342 |
|---|
| Common shares issued upon acquisition | - | - | - | - | - | - | - | - | - | - | 136 |
|---|
| Contingent consideration issued upon acquisition | - | - | - | - | - | - | - | - | - | - | 21 |
|---|
| Common shares issued upon settlement of debt | - | - | - | - | - | - | - | - | - | - | 10 |
|---|
| Earn out shares issued in settlement of contingent liability | - | - | - | - | - | - | - | - | - | - | 4 |
|---|
| Options issued in settlement of debt | - | - | - | - | - | - | - | - | - | - | 489,000 |
|---|
| Settlement of notes payable | - | - | - | - | - | - | - | - | - | - | 418,503 |
|---|